Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Istaroxime

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Windtree Therapeutics to Release Istaroxime Study Interim Results
    Windtree Therapeutics to Release Istaroxime Study Interim Results

    22 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/22/3086575/0/en/Windtree-Therapeutics-Announces-Istaroxime-Cardiogenic-Shock-SCAI-Stage-C-Phase-2-Study-Planned-Interim-Analysis-Results-Targeted-for-July-2025.html

    GLOBENEWSWIRE
    22 May 2025
    Share Share
    Windtree Shares Istaroxime Data at ESC Heart Failure Conference
    Windtree Shares Istaroxime Data at ESC Heart Failure Conference

    19 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/19/3083943/0/en/Windtree-Therapeutics-Announces-Istaroxime-Presentation-at-European-Society-of-Cardiology-Heart-Failure-Conference.html

    GLOBENEWSWIRE
    19 May 2025
    Share Share
    Windtree Therapeutics Presents Preclinical Data on Istaroxime
    Windtree Therapeutics Presents Preclinical Data on Istaroxime

    12 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/12/3079054/0/en/Windtree-Therapeutics-Announces-Presentation-of-Preclinical-Data-on-Istaroxime-and-a-Selective-SERCA2a-Activator-at-the-European-Society-of-Cardiology-Heart-Failure-Conference-May-.html

    GLOBENEWSWIRE
    12 May 2025
    Share Share
    Windtree Secures Istaroxime Patent Allowance For Acute Heart Failure
    Windtree Secures Istaroxime Patent Allowance For Acute Heart Failure

    04 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/04/3036439/0/en/Windtree-Announces-Istaroxime-Notice-of-Allowance-from-the-U-S-Patent-and-Trademark-Office-for-Acute-Heart-Failure.html

    GLOBENEWSWIRE
    04 Mar 2025
    Share Share
    Windtree To Present Istaroxime Data At Heart Failure Conference
    Windtree To Present Istaroxime Data At Heart Failure Conference

    12 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/12/3024995/0/en/Windtree-Announces-Special-Late-Breaking-Clinical-Science-Abstract-Presentation-on-Istaroxime-at-the-Technology-and-Heart-Failure-Therapeutics-Conference.html

    GLOBENEWSWIRE
    12 Feb 2025
    Share Share
    Windtree Files New Istaroxime Patent for Myocardial Arrhythmia
    Windtree Files New Istaroxime Patent for Myocardial Arrhythmia

    09 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/09/2993691/0/en/Windtree-Announces-New-Istaroxime-Patent-Filing-for-Preventing-or-Reducing-the-Risk-of-Acute-Myocardial-Arrhythmia.html

    GLOBENEWSWIRE
    09 Dec 2024
    Share Share